News search

E.g., 25/11/2024
E.g., 25/11/2024
Alexandra
Miguel Palomino Segura, Georgiana Crainiciuc, Jon Sicilia y Andrés Hidalgo
Research
5 Jan 2022

Scientists at the CNIC have developed a simple model for studying the behavior of immune cells in live animals and have identified a harmful cell behavior pattern associated with cardiovascular disease


Alfonso Mora, Ayelén Santamans, Luis Leiva, Guadalupe Sabio, José Antonio Enríquez y Barbara Gonzalez Terán.
Research
24 Nov 2021

The study, published in PLoS Biology, shows for the first time that cardiac metabolism in the postnatal period determines the regulation of metabolism in the whole body

David Sancho y Carlos del Fresno
Research
18 Nov 2021

Immune therapy based on nasal administration of a preparation of dead bacteria called MV130 prevents death in experimental animals infected with the SARS-CoV-2 coronavirus and increases the immunogenicity of COVID-19 vaccines

Rebeca Piñeiro, Joaquim Grego-Bessa, Vitor Samuel Leite, Luis luna-Zurita
Research
12 Nov 2021

A study published in Science Advances shows that the gene GPR126, while not required for the development of the heart, plays an essential role in the formation of the placenta, the gestational organ that nourishes the fetus

Álvaro Macías, Jesús Vázquez, Pilar Gonzalo, Carla Espinós, Beatriz Dorado, Emilio Camafeita, Vicente Andrés, María J Andrés, Cristina González, Amanda Sánchez, Víctor Fanjul.
Research
26 Oct 2021

Scientists from the CNIC and the CIBERCV have generated the first experimental animal model that develops Hutchinson-Gilford Progeria Syndrome and allows its controlled reversal


De izquierda a derecha: Enrique Lara-Pezzi, Laura Lalaguna, Laura Ramos, Elena González, María Villalba, Claudia Camarero, Marina López, Betel Olaizola, Ascensión Rey, Carlos Martí, Elísabet Bello y Javier Larrasa
Research
3 Sep 2021

The new findings, published in Circulation Research, could spur the development of new tools for the treatment of cardiac hypertrophy

About the CNIC
6 Aug 2021

CNIC and the Mario Negri Institute in Milan (Italy) coordinate REBOOT, a project that aims to study whether treatment with beta-blockers is beneficial for patients who have suffered a myocardial infarction

About the CNIC
2 Aug 2021

Akiko Iwasaki, with some other scientists, helped create a plan to stop Covid-19. She has also spoken out about the barrier’s women face in the field of biology

Grupo de la Dra. Priori
Research
21 Jul 2021

The research team led by project leader Dr Silvia Priori is confident that the discovery of new therapies will reduce the mortality linked to this disease and could also reduce arrhythmias in heart failure patients